You can try to connect everything to sigma 1 receptor but as long as company is not saying anything about it all talks are vapor ware.
Company is a CNS disease company and sticking to it.
Many BP have announced pausing trials and that is likely to impact Rett and ALZ enrollments. Many hospitals have stopped the trial intake or follow up visits to avoid contacts. This is impacting large number of current trials.
AVXL best bet is PDD as enrollment was completed in Jan. However Spain is badly impacted and not sure how it will impacted 14 week reading for last batch patients. If that cannot happen the trial results will be delayed.